Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Florida
University of Michigan Rogel Cancer Center
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
Emory University
University of Florida
University of Florida
University of Florida
University of Florida
Duke University
Baptist Health South Florida
City of Hope Medical Center
Dana-Farber Cancer Institute
Pfizer
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Baptist Health South Florida
Dana-Farber Cancer Institute
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Dana-Farber Cancer Institute
Iambic Therapeutics, Inc
Sunnybrook Health Sciences Centre
Columbia University
Stanford University
University of Pennsylvania
University of Alabama at Birmingham
Duke Street Bio Ltd
M.D. Anderson Cancer Center
Augusta University
Medical College of Wisconsin
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Baptist Health South Florida
AstraZeneca
Seattle Children's Hospital
Henry Ford Health System
Seattle Children's Hospital
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
Assistance Publique - Hôpitaux de Paris
Seattle Children's Hospital
Memorial Sloan Kettering Cancer Center
University of Texas Southwestern Medical Center
National Cancer Institute (NCI)